Rolf Kaiser

This study examines how HCV replication fitness affects antiviral treatment outcomes, finding that high replication fitness can compensate for resistance mutations and contribute to DAA treatment failure.

The paper develops a web service called geno2pheno[bNAbs] that predicts HIV-1 resistance to broadly neutralizing antibodies using statistical models and compares its performance to other methods.

The paper introduces a Bayesian regression model to detect HLA-associated mutations by integrating multiple sources of information, improving detection performance over existing methods.